Multiclass <scp>HCV</scp> resistance to direct‐acting antiviral failure in real‐life patients advocates for tailored second‐line therapiesVelia Chiara Di Maio, Francesca Ceccherini‐Silberstein, Vincenza Calvaruso et al.|Liver International|2017Cited by 90
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levelsVelia Chiara Di Maio, Valeria Cento, M. Aragri et al.|Journal of Antimicrobial Chemotherapy|2015Cited by 13
Hepatitis C virus RNA levels at week-2 of telaprevir/boceprevir administration are predictive of virological outcomeValeria Cento, Francesca Ceccherini‐Silberstein, Daniele Di Paolo et al.|Digestive and Liver Disease|2014Cited by 5
Multiclass hepatitis C virus resistance to direct acting antivirals in real life interferon-free regimens failures advocates for tailored second-line therapiesVelia Chiara Di Maio, M. Paoloni, Valeria Cento et al.|Journal of Hepatology|2017Cited by 2
In the ERA of New Direct Acting Antiviral Agents HCV Sequencing Allows the Most Accurate Subtype and Genotype AssignmentM. Aragri, Giustino Parruti, Velia Chiara Di Maio et al.|Journal of Hepatology|2016Cited by 1